Daito Pharmaceutical Company Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daito Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Fuji Pharma Company Limited
sales of 35.39 billion Japanese Yen [US$325.56 million]
of which 100%
was Pharmaceutical Business),
JCR Pharmaceuticals Co., Ltd.
(18.09 billion Japanese Yen [US$166.38 million]
of which 98%
was Pharmaceutical Business), and
Taiko Pharmaceutical Company., Limited
(8.29 billion Japanese Yen [US$76.31 million]
of which 61%
was Medicine Goods).
During the year ended May of 2017, sales at
Daito Pharmaceutical Company Limited were ¥37.98 billion (US$349.46 million).
increase of 4.4%
versus 2016, when the company's sales were ¥36.37 billion.
This was the fifth consecutive year of sales increases at Daito Pharmaceutical Company Limited
(and since 2012, sales have increased a total of 40%).
Sales of Formulation saw an increase
7.2% in 2017, from
¥14.34 billion to ¥15.37 billion.